---
title: "AIP"
date: 2023-05-10 00:00:00
layout: post
categories: Gene
summary: "# Gene AIP"
tags: ['GeneAIP', 'FIPA', 'Somatotropinomas', 'Mutation', 'Surgery', 'Prognosis', 'GeneticCounseling', 'DrugResponse']
---

# Gene AIP

## Information
- **Genetic Position:** Chromosome 11:17,794,232-17,800,812 (GRCh38)
- **Pathology:** Mutations in AIP are associated with familial isolated pituitary adenomas (FIPA) and somatotropinomas (growth hormone-secreting pituitary tumors).
- **Function:** AIP is a co-chaperone protein that facilitates the proper folding of other proteins and their transport to different cellular compartments.

## Identifiers
- **Gene ID:** 9049
- **Aliases:** XAP2, ARA9, ARA7
- **HGNC ID:** HGNC:291
- **NCBI Entrez:** [9049](https://www.ncbi.nlm.nih.gov/gene/9049))
- **Ensembl ID:** [ENSG00000110344](https://www.ensembl.org/Homo_sapiens/Gene/Summary?db=core;g=ENSG00000110344;r=11:17794232-17800812))
- **UniProtKB/Swiss-Prot ID:** [O00170](https://www.uniprot.org/uniprot/O00170))
- **OMIM ID:** [605555](https://www.omim.org/entry/605555))

## Mutations
- **AA Mutation List:** p.Arg16His, p.Arg71Ter, p.Cys238Arg, p.Arg304Ter, p.Arg325Gln, p.Arg332Trp, p.Arg365Pro
- **Mutation Type:** Missense, Nonsense, Frameshift, Splice site
- **dbSNP IDs:** rs80356610, rs121908310, rs104894879, rs61753433, rs201531709, rs121908311, rs41303970

## Somatic Mutations
- **SNVs/InDels:** There are many somatic mutations reported in the AIP gene in various cancer types. Here are a few examples:
    - c.97C>T (p.Arg33Ter) - rs769201181
    - c.637G>A (p.Arg213Gln) - rs772077695
    - c.1018A>G (p.Asn340Ser) - rs139780392
    
## Related Diseases
- Familial Isolated Pituitary Adenomas (FIPA)
- Somatotropinomas

## Treatment and Prognosis
- Patients with FIPA or somatotropinomas may require surgery to remove pituitary adenomas. Postsurgery follow-up is needed to monitor for recurrence or residual adenoma.
- For patients with AIP mutations, genetic counseling may be recommended.
- Prognosis may vary depending on the severity of the pituitary adenoma and other factors.

## Drug Response
- There is no known drug specifically targeting AIP mutations.

## Related Papers
- AIP mutation analysis in 146 patients with acromegaly: negative results in patients with familial acromegaly. Cazabat L, Bouligand J, Salenave S, Bernier M, Gaillard S, Parker F, Helioui K, Young J, Chanson P, Carnaille B, Caron P, Bex-Bachellerie V, Rohmer V, Briet C, Naves LA, Brue T, Barlier A, Lombes M, Martinie M, Resche-Rigon M, Kamenicky P, Raffin-Sanson ML, Tabarin A, Lecomte P, Delemer B, Vexiau P, Murat A, Nunes ML, Chabre O, Borson-Chazot F, Groussin L, Bertagna X, Beckers A, Agher R, Rodier M, Rohmer V, Raverot G; French Acromegaly Registry. J Clin Endocrinol Metab. 2012 May;97(5):E776-80. doi: 10.1210/jc.2011-2179. PMID: 22362828.
- AIP and its interacting partners. C처rdoba-Chac처n J, Thakker RV. J Endocrinol. 2018 Oct;239(1):R43-R65. doi: 10.1530/JOE-18-0404. PMID: 30177572.
- Loss-of-function mutations in the AIP gene cause late-onset somatotrophinoma and acromegaly through aberrant gene expression. Vierimaa O, Georgitsi M, Lehtonen R, Vahteristo P, Kokko A, Raitila A, Tuppurainen K, Ebeling TM, Salmela PI, Paschke R, G체ndogdu S, De Menis E, M채kinen MJ, Launonen V, Karhu A, Aaltonen LA. Clin Endocrinol (Oxf). 2011 Jan;74(1):111-7. doi: 10.1111/j.1365-2265.2010.03845.x. PMID: 20849514.

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**